Autorisation d’accès précoce refusée à la spécialité DUPIXENT (dupilumab).
See also
Décision d'accès précoce
14/11/2024
eNrlWF1v2jAUfedXoLw7HxTKmALVxtoNqdUYLdq0l8o4FzAzduoPoPv1cxK60SlR11C/dC/I2PG91/Y55147PtutWXMDUlHB+17kh14TOBEJ5Yu+N725QG+8s0EjXuENPvis64d+1PKahGGl+l426s8Ac+V/u7r8AHY+SG/QaMZitgKiH31nNGX+J6yWVzjNvmnGG0GT5hr0UiR9LzU6723GSksbxWAr5A+VYgJxsO85HF3dtg/74yAz9g9WjQJ5ifmi1CjwWjaJkRK4HmINCyHvK+I9qWWbqgkoYSSBMdbLsRQbmkBS6mKOmYJaTubb5BrkhoHOnJQaD1ZkrWoZxyu8m8DdqDzod3Z0qHcahSjqdnvtbrcTtTud01qu5MFWlZ+CXUSQ3p50OmGv2wuABwkQmoEbcdQKW20UtrphkJBAwRolBkUhEkSLmYRi2HYRwRgsACWAGEZLbDQg+yMk1Xmnwtw2UiG1bSAJc6NQgjAhoFAqLUfIw1yVWueY5fNMSncWQ3mDmTWe1UTLOPPLHOGEquFjqDvyI+HuSTwmVKUM3/srldbdKiyxHQZpBcndQrIV3Egrkczu2V/2uWEseGbU072AOYo408ehMFxX6NjFpO5GDIXlxa76ROtJr97tsUhBvZzZn4KXp52xmTFK6oqslUEDSk8no2qNfd3y9B4rmEp3+vSV8kRs1cvr3iHOHEWfnwkrNZrKJLpt9d6cRp1ObVp/t6CuyMLnRooUAquIVB0jdCM+F8dKnOVJuakHlrxiguTVqSCYQUV9imrqr2XGQzntjHvueF0MlBr9eH5TF7BfDMj76/xvqWma9H9DrV5ycpHxLD0qA38+2QrNcXJzMbJcy5Zap+ptEGy3W3+JVcE3fy7/g+x3UAK5u8k5qbOKurPIII5CnxWlwfMwU5f7T1Vix94u9vP3t5hSH1oaOOIsijThTMxH5y+fH/5cLZyFPX6kZ+7c5NcArK02uSoGzay8EjwqI9lz5RfSCsTn+ZxWvKxV4jIOile9QSMOshe9QeMXvZiyCw==
78ysv6Q7DxZ6ABf1